Xeris Company Profile
✉ Email this page to a colleague
What is the competitive landscape for XERIS, and when can generic versions of XERIS drugs launch?
XERIS has two approved drugs.
There are two US patents protecting XERIS drugs.
There are twenty-one patent family members on XERIS drugs in fifteen countries.
Drugs and US Patents for Xeris
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xeris | DARANIDE | dichlorphenamide | TABLET;ORAL | 011366-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Xeris | GVOKE HYPOPEN | glucagon | SOLUTION;SUBCUTANEOUS | 212097-004 | Sep 10, 2019 | RX | Yes | Yes | 9,649,364 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Xeris | GVOKE HYPOPEN | glucagon | SOLUTION;SUBCUTANEOUS | 212097-003 | Sep 10, 2019 | RX | Yes | Yes | 9,649,364 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Xeris | GVOKE PFS | glucagon | SOLUTION;SUBCUTANEOUS | 212097-001 | Sep 10, 2019 | DISCN | Yes | No | 11,590,205 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Xeris Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Denmark | 3352780 | ⤷ Try a Trial |
Brazil | 112018005800 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2017053922 | ⤷ Try a Trial |
Japan | 6835831 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.